ReviewCureus2026
Apoptosis, Mitosis, and Cell Turnover in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma: A Narrative Review on Histochemical Assessment and Clinicopathological Relevance.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Maintenance of oral epithelial integrity depends on the equilibrium between cellular proliferation, differentiation, and programmed cell death. Disruption of this equilibrium contributes to the development and progression of oral potentially malignant disorders (OPMDs) and oral squamous cell carcinoma (OSCC). Apoptotic index (AI), mitotic index (MI), turnover index (TI), and nuclear-cytoplasmic morphometric parameters provide measurable representations of epithelial kinetics and cytological atypia. This narrative review examines alterations in these parameters across oral leukoplakia, oral epithelial dysplasia (OED), oral submucous fibrosis (OSMF), and OSCC. It also evaluates hematoxylin and eosin (H&E), methyl green-pyronin Y, Feulgen, fluorescent Feulgen, and acridine orange staining for identifying apoptotic bodies, mitotic figures, and nuclear alterations. Available evidence indicates that apoptotic and proliferative activity generally increases with epithelial dysplasia and malignancy, although the relationship is not consistently linear. Histochemical techniques can enhance nuclear contrast and facilitate quantitative assessment, particularly in settings where immunohistochemistry or molecular testing is unavailable. Nevertheless, variation in fixation, staining, field selection, counting criteria, and observer calibration limits comparison across studies. Moreover, associations with histological grade should not be interpreted as evidence of prognostic prediction without longitudinal clinical outcomes. Standardized counting protocols, appropriate normal controls, blinded observer assessment, digital image analysis, and validation against established proliferation and apoptosis markers are required. Quantitative cell-turnover assessment should presently be regarded as an adjunct to conventional histopathological diagnosis rather than a replacement for established grading systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.